SUBSCRIBE
SUBSCRIBE

Indications

PRESS RELEASES
Press Releases
Laverock Therapeutics Reports Key Oncology Research Milestones
June 10, 2026
 · 
2 min read
Press Releases
Multi Radiance Medical Expands FDA-Cleared Indications with New Lateral Epicondylitis Clearance Following Successful Triple-Blind Clinical Trial
June 9, 2026
 · 
4 min read
Press Releases
Telitacicept Receives NMPA Conditional Approval for the Treatment of IgA Nephropathy in China
June 8, 2026
 · 
6 min read
Press Releases
Press Release: Sanofi’s Sarclisa subcutaneous approved in the EU as the first anticancer treatment administered via an on-body injector
June 8, 2026
 · 
12 min read
Press Releases
Tenaya Therapeutics Announces Interim Data from MyPEAK™-1 Showing Treatment of MYBPC3-associated HCM with TN-201 Gene Therapy Resulted in Consistent Signs of Cardiac Remodeling and Reductions in Symptoms
June 3, 2026
 · 
13 min read
Press Releases
KORTUC Launches Global Cervical Cancer Study, Expanding Pipeline to Second Indication
June 3, 2026
 · 
3 min read
Press Releases
Immatics Presents Data on IMA401 MAGEA4/8 Bispecific at 2026 ASCO Annual Meeting with Simultaneous Publication in Nature Medicine Supporting Development of IMA401/IMA402 Combination in Lung Cancer
June 1, 2026
 · 
11 min read
Press Releases
Bausch Health’s Aesthetic Business, Solta Medical, Earns Prestigious Trademark Certification of Thermage® in China
May 29, 2026
 · 
5 min read
Press Releases
Mabwell Announces NMPA Approval of Supplemental Application for Additional Indications of MAIWEIJIAN (Denosumab Injection)
May 21, 2026
 · 
5 min read
Press Releases
Eisai Deepens Body of Clinical Evidence for LENVIMA (Lenvatinib) Across Established Indications at ASCO 2026
May 20, 2026
 · 
26 min read
Press Releases
JASCAYD® (nerandomilast) approved in Japan, advancing global access to a new IPF and PPF treatment
May 18, 2026
 · 
8 min read
Press Releases
ENHERTU® (fam-trastuzumab deruxtecan-nxki) approved in the US for two new indications for patients with HER2-positive early breast cancer
May 17, 2026
 · 
19 min read
Press Releases
Enhertu® Approved in the U.S. for Two New Indications for Patients with HER2 Positive Early Breast Cancer
May 17, 2026
 · 
19 min read
Press Releases
Tiziana Reports Reduced Brain Inflammation in Multiple System Atrophy Patients Treated with Intranasal Foralumab
May 14, 2026
 · 
6 min read
Press Releases
European Commission Approves Pfizer’s HYMPAVZI for the Treatment of Adults and Adolescents with Hemophilia A or B With Inhibitors
May 13, 2026
 · 
16 min read
Press Releases
CardioPharma Reviews Applications to Explore Non-Cardiovascular Benefits of CVD Polypill
May 12, 2026
 · 
4 min read
Press Releases
FDA Advances Drug Repurposing to Address Unmet Medical Needs
May 11, 2026
 · 
3 min read
Press Releases
Avenacy Announces Launch of Ready-to-Use Tranexamic Acid in 0.7% Sodium Chloride Injection in the U.S. Market
May 11, 2026
 · 
2 min read
Press Releases
LIB Therapeutics Launches LEROCHOL® (lerodalcibep-liga) in the United States with a Patient-First Approach to Access and Affordability
May 11, 2026
 · 
6 min read
Press Releases
Innovent Announces IBI363 (PD-1/IL-2α-bias Bispecific Fusion Protein) Received Third NMPA Breakthrough Therapy Designation for MSS/pMMR Metastatic Colorectal Cancer
May 11, 2026
 · 
5 min read
Load More